Our Vision

To develop therapies targeting fibroblasts & macrophages that will benefit patients suffering from fibrosis, cancer, infection and autoimmunity.

Our Mission

To uncover the foundational aspects of fibroblast & macrophage biology required to discover and actuate therapeutic targets.

Latest Publications

Adventitial fibroblast–ILC2 niche restrains liver fibrosis

Nature Reviews Immunology, 2023

What’s in a name? An emerging framework for cancer-associated fibroblasts, myofibroblasts, and fibroblasts

Cancer Cell, 2022

Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer

Immunity, 2021

Cross-tissue organization of the fibroblast lineage

Nature, 2021